TITLE:
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

CONDITION:
Pneumonia

INTERVENTION:
Recombinant Chimeric Monoclonal Antibody

SUMMARY:

      The objective of this study is to demonstrate the safety and efficacy of IC14 in the
      treatment of hospitalized patients with community-acquired pneumonia and sepsis.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Current diagnosis of community-acquired pneumonia.

          -  Evidence of systemic inflammatory response to infection.

        Exclusion Criteria:

          -  Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the
             investigator.

          -  Presence of organ failure.
      
